The new Rutgers REACH hub will identify innovative health-related technologies by using the expertise of the National Cancer Institute-funded Rutgers Cancer Institute, RITMS, and the New Jersey Center for Biomaterials (NJCBM). These technologies will be evaluated for commercialization feasibility, especially as they relate to providing precision therapy to tackle an unmet need created by the heterogeneity of disease development and response to treatment. Addressing such needs can provide assets tailored to patients’ therapeutic responses that ultimately improve health. To learn more about the hub.
Home / News / From NJBIZ.com: Rutgers ROI Program to integrate strengths in biomedical sciences, expertise in research commercialization
Recent Posts
- Why Research on Tuberculosis Prevention and Treatment is Even More Relevant Today.
- How Parenthood May Help Keep Your Brain Young.
- New Study Raises Alarm Over Alzheimer’s Blood Tests.
- How a junk-food splurge can change your brain activity.
- Princeton Precision Health: An interdisciplinary, AI-driven approach to tackling big questions about health and disease.
Categories
- Community (2,181)
- Covid (983)
- CTO Events (6)
- News (2,786)
- Pilots (21)